基石科技(08391.HK)折让约16.7%配股 最多净筹约4,712万元
基石科技控股(08391.HK)公布,拟向最少六名承配人按配售价每股0.4元配售最多4,962.5万股新股,并再向公司执董及高层管理人员之联系人配发6,962.5万股新股。配售价较公司股份昨日(15日)收市价每股0.48元折让约16.7%。
配售最多4,962.5万股新股相当於公司於已发行股本约10.33%;及经扩大已发行股本约9.36%。另外配发6,962.5万股新股相当於於已发行股本约14.49%;及经扩大後已发行股本约11.61%。
配售及认购事项最多所得款项净额将约为4,712万元,拟用於电动车充电业务发展、商业及财经印刷业务、营运资金及一般企业用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.